Abnormal Uterine Bleeding
Reproductive Health
Abnormal Uterine Bleeding is treated with 4 medications in our database, including Norethindrone, Medroxyprogesterone Acetate, medroxyprogesterone acetate, Amidate. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Pfizer, Hospira. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Abnormal Uterine Bleeding treatment below.
What help exists for Abnormal Uterine Bleeding
9
drugs indexed
6
with copay cards
6
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Abnormal Uterine Bleeding
9 totalHydroxyprogesterone Caproate
Hydroxyprogesterone Caproate Β· Covis
ππNORETHINDRONE
norethindrone acetate and ethinyl estradiol Β· Pfizer
Ovidrel
choriogonadotropin alfa Β· EMD Serono
Conjugated Estrogens
CONJUGATED ESTROGENS Β· Pfizer
ππProvera
medroxyprogesterone acetate Β· Pfizer
ππAmidate
ETOMIDATE Β· Hospira
ππMEDROXYPROGESTERONE ACETATE
Medroxyprogesterone acetate Β· Pfizer
ππMedroxyprogesterone
Medroxyprogesterone acetate Β· Pfizer
ππGallifrey
Norethindrone Acetate Β· Invalid Entry
π = copay card Β· π = patient assistance program
Prior authorization patterns for Abnormal Uterine Bleeding drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 12 PA rules for Abnormal Uterine Bleeding drugs. View individual drug pages for complete PA detail.